Cryptos: 39,233 Exchanges: 362 Market Cap: $4,860.2B 24h Vol: $111.03B Dominance: BTC 37.9% ETH 8% ETH Gas:  0 Gwei
Seclect Currency

Fiat currencies

    Crypto Currencies

      No results for ""

      We couldn't find anything matching your search.Try again with a different term.

      Tharimmune's Logo

      Tharimmune - Post-IPO

      Overview Investors Company Profile / Project Introduction

      Overview

      Funding Date

      November 4, 2025

      Financing amount

      $540M

      Valuation

      --

      Category

      CeFi

      Subcategory

      --

      About Tharimmune - Post-IPO

      Tharimmune raised $540 million in a private placement led by DRW and Liberty City Ventures to launch a canton coin–based treasury strategy. The Canton Foundation and major firms including ARK Invest, Kraken, Polychain Capital, and Tradeweb joined the round. The move makes Tharimmune the first public company aligned with the Canton Network, as it shifts toward operating validators and building institutional blockchain infrastructure.

      Investors

      InvestorsTypeLocationYear Founded#Portfolio CompaniesEmail AddressSocials
      Fund United States of America 2012 34 [email protected]
      Fund United States of America 1992 14 --
      Corporate -- -- 49 --
      Fund United States of America 2016 178 [email protected]
      Corporate United States of America 2014 4 --

      Company Profile / Project Introduction

      Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.

      View More
      *Fundraising Announcement: Click here